Compound information
- Natural Products
- ZC1306408
- Molecular Formula
- C25H29N3O6
- Molecular Weight
- 467.205635648 g/mol
- Structure
-
- IUPAC Name
- benzyl 2-[[(2S)-1-[(2S)-2-(benzyloxycarbonylamino)propanoyl]pyrrolidine-2-carbonyl]amino]acetate
- InChI
- InChI=1S/C25H29N3O6/c1-18(27-25(32)34-17-20-11-6-3-7-12-20)24(31)28-14-8-13-21(28)23(30)26-15-22(29)33-16-19-9-4-2-5-10-19/h2-7,9-12,18,21H,8,13-17H2,1H3,(H,26,30)(H,27,32)/t18-,21-/m0/s1
- InChI Key
- HCUDQCNGONAVAR-RXVVDRJESA-N
- SMILES
- C[C@H](NC(=O)OCc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)OCc1ccccc1
- Source
- ZINC000019891860
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 3 |
Heteroatom Count | 9 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 114.04 Å2 | LogP | 2.625 |
LogS | -3.606 | LogD | 3.562 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.004 | Pgp substrate | 0.169 |
HIA | 0.819 | F20 % | 0.95 |
F30 % | 0.002 | Caco-2 | -5.048 |
MDCK | -4.947 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.0 | PPB | 93.64 |
VD | 0.503 | Fu | 1.256 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.009 | CYP1A2 substrate | 0.531 |
CYP2A6 substrate | 0.45 | CYP2B6 substrate | 0.568 |
CYP2C19 inhibitor | 0.343 | CYP2C19 substrate | 0.863 |
CYP2C8 substrate | 0.809 | CYP2C9 inhibitor | 0.059 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.311 |
CYP2D6 substrate | 0.728 | CYP2E1 substrate | 0.274 |
CYP3A4 inhibitor | 0.218 | CYP3A4 substrate | 0.977 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.848 | CL | 7.158 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.019 | Hepatotoxicity | 0.771 |
Mutagenicity | 0.011 | Rat Oral Acute Toxicity | 0.48 |
FDAMDD | 0.671 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.001 | Eye Corrosion | 0.004 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.064 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.268 | IGC50 | 3.572 |
LC50FM | 1.257 | LC50DM | 4.211 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.168 | NR-AR-LBD | 0.216 |
NR-AhR | 0.006 | NR-Aromatase | 0.036 |
NR-ER | 0.25 | NR-ER-LBD | 0.412 |
NR-PPAR-gamma | 0.199 | SR-ARE | 0.246 |
SR-ATAD5 | 0.517 | SR-HSE | 0.193 |
SR-MMP | 0.045 | SR-p53 | 0.025 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.